What they were paid
Vir Biotechnology Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $87,170 | $39,520 | $57,955 | $0 | $184,645 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vir Biotechnology, Inc. DEF 14A filed April 16, 2026, accession 0001628280-26-025379, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Vir Biotechnology pays directors a $50,000 cash retainer and $385,000 in Options and RSUs.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance (Chair)
The rest of the Vir Biotechnology board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Elliott Sigal | Independent Director | $187,505 |
| Janet Napolitano | Independent Director | $159,975 |
| Marianne De Backer | Director | $0 |
| Norbert Bischofberger | Independent Director | $176,661 |
| Ramy Farid | Independent Director | $164,975 |
| Robert More | Independent Director | $182,860 |
| Saira Ramasastry | Independent Director | $180,126 |
| Vicki Sato | Chair of the Board | $184,975 |
The full Vir Biotechnology compensation record
free company briefThis page is one director within Vir Biotechnology's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat